+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report by Product (Controls, Calibrators), Type (Quality Control, Quality Assurance Services), Application, Manufacturer Type, End-use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • Grand View Research
  • ID: 4761222
Description Jump to:
The global in vitro diagnostics quality control market size is expected to reach USD 1.59 billion by 2030, registering a CAGR of 3.2% from 2024 to 2030. The continually evolving technology-oriented changes in the diagnostics field and the growing requirement to ensure patient safety necessitate the execution of quality assurance programs in several medical domains including point-of-care devices and radiology.The patients rely on self-testing in vitro diagnostics (IVD) devices for long-term disease management and hence it is important for such IVD devices to be checked for quality in terms of result reproducibility and validity to guarantee patient safety.

The rising number of certified clinical laboratories offering dependable IVD-based diagnostic services directly correlates with increased patient confidence, thus driving market growth. Some of the key pathogens routinely diagnosed using multiplex PCR, but not limited to, are HIV, HSV (meningitis and encephalitis), H. influenza, S. pneumonia (respiratory tract infections), N. gonorrhea, C. trachoma (genital infections), G. lambardia, C. parvum (diarrheal diseases), and Leishmaniaspp (Leishmaniasis).In addition to assessments, amendments to the regulatory framework are made intermittently to enhance the present standards with the main objective of safeguarding the qualitative superiority of the diagnostic services rendered to patients.

Quality control in the laboratory is focused on ensuring that the results delivered to the patient are accurate. Control checks are usually undertaken while installing an instrument, after servicing, changing reagent lots, and when the instrument readings are not in range.Home care settings include a variety of devices, such as point-of-care (PoC) instruments used for near-patient bed testing, self-testing kits, and IVD devices in assisted healthcare settings. Self-testing kits giveease of convenience for patients who require everyday testing and further reduce hospital visits.

In Vitro Diagnostics Quality Control Market Report Highlights

  • In 2023, the clinical chemistry segment held the largest share of the market. The increasing demand for preventive medicine and the rapid transformation of clinical laboratories into highly automated and efficient businesses are some of the factors responsible for its high market share
  • The quality control segment dominated the market in 2023 and is estimated to grow at the highest CAGR over the forecast period. Quality control in the research laboratory is concentrated on certifying the results provided to the individuals are precise
  • The hospital segment held the largest share in 2023 due to the presence of highly advanced technology-based devices, such as Next Generation Sequencing (NGS), mass spectrophotometry, and microarrays, and the rising applications of the optimized quality-control procedures
  • Many pharmaceutical companies are implementing the new draft guidance enforced by the U.S. FDA for data integrity on current Good Manufacturing Practices (cGMP)
  • It provides information in relation to establishing robust operating procedures and strong management systems, obtaining high-quality raw materials, investigating deviations, and maintaining reliable diagnostic laboratories

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation
1.1.1. Regional Scope
1.1.2. Market Definitions
1.1.3. Estimates and Forecasts Timeline
1.2. Objectives
1.2.1. Objective - 1
1.2.2. Objective - 2
1.2.3. Objective - 3
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis (Model 1)
1.7.1.1. Approach 1: Commodity Flow Approach
1.7.1.2. Approach 2: Country Wise Market Estimation Using Bottom-up Approach.
1.8. List of Secondary Sources
1.9. List of Abbreviations
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. By Product and Type Segment Snapshot
2.3. By Application and Manufacturer Type Segment Snapshot
2.4. By End-use Segment Snapshot
2.5. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Number of Accredited Clinical Laboratories
3.2.1.2. Increasing Third-party Quality Control Services
3.2.1.3. Presence of Favorable Regulatory Bodies
3.2.2. Market Restraint Analysis
3.2.2.1. High Cost of IVD Quality Control Services
3.2.2.2. Unfavorable Reimbursement Scenario in IVD Industry
3.2.3. Opportunity Analysis
3.2.4. Supply Chain Analysis
3.3. Business Environment Analysis
3.3.1. PESTEL Analysis
3.3.2. Porter’s Five Forces Analysis
Chapter 4. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Product, 2018-2030 (USD Million)
4.1. In Vitro Diagnostics Quality Control Market: Product Movement Analysis
4.2. In Vitro Diagnostics Quality Control Market Estimates & Forecast, by Product (USD Million)
4.2.1. Controls
4.2.1.1. Total Protein
4.2.1.2. Albumin
4.2.1.3. Blood Urea Nitrogen
4.2.1.4. Uric Acid
4.2.1.5. Creatinine
4.2.1.6. Sodium
4.2.1.7. Potassium
4.2.1.8. Chloride
4.2.1.9. Calcium
4.2.1.10. Magnesium
4.2.1.11. Inorganic Phosphorus
4.2.1.12. Aspartate Transaminase
4.2.1.13. Creatine Kinase
4.2.1.14. Gamma Glutamyl Transferase
4.2.1.15. Total Bilirubin
4.2.1.16. C-Reactive Protein
4.2.1.17. Glucose
4.2.1.18. Iron
4.2.1.19. Alanine Transaminase
4.2.1.20. Alkaline Phosphatase
4.2.1.21. Alpha-amylase
4.2.1.22. Total Cholesterol
4.2.1.23. Triglyceride
4.2.1.24. Lactate Dehydrogenase
4.2.1.25. Immunoglobulin G
4.2.1.26. Immunoglobulin a
4.2.1.27. Immunoglobulin M
4.2.1.28. Complement 3
4.2.1.29. Complement 4
4.2.1.30. Rheumatoid Factor
4.2.1.31. Anti-Streptolysin -O
4.2.1.32. Beta 2 Microglobulin
4.2.1.33. Cystatin-C
4.2.1.34. Myoglobin
4.2.1.35. Troponin t and I
4.2.1.36. Others
4.2.2. Calibrators
4.2.3. Others
Chapter 5. In Vitro Diagnostics Quality Control Market: Segment Analysis, by Type, 2018-2030 (USD Million)
5.1. In Vitro Diagnostics Quality Control Market: Type Movement Analysis
5.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Type (USD Million)
5.2.1. Quality Controls
5.2.1.1. Plasma-based Control
5.2.1.2. Serum-based Control
5.2.1.3. Whole Blood-based Control
5.2.1.4. Others
5.2.2. Quality Assurance Services
5.2.3. Data Management Solutions
Chapter 6. In Vitro Diagnostics Quality Control Market: By Application Estimates & Trend Analysis
6.1. In Vitro Diagnostics Quality Control Market: Application Movement Analysis
6.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Application (USD Million)
6.3. Immunochemistry
6.4. Hematology
6.5. Clinical Chemistry
6.5.1.1. Alkaline Phosphatase (ALP)
6.5.1.2. Alanine Transaminase (ALT)
6.5.1.3. Aspartate Transaminase (AST)
6.5.1.4. Creatine Kinase MB (CK-MB)
6.5.1.5. Albumin
6.5.1.6. Creatinine
6.5.1.7. Glucose
6.5.1.8. Triglycerides
6.5.1.9. Amylase
6.5.1.10. Others
6.5.2. Molecular Diagnostics
6.5.3. Coagulation
6.5.4. Microbiology
6.5.5. Others
Chapter 7. In Vitro Diagnostics Quality Control Market: By Manufacturer Type Estimates & Trend Analysis
7.1. In Vitro Diagnostics Quality Control Market: Manufacturer Type Movement Analysis
7.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by Manufacturer Type (USD Million)
7.2.1. Third-party Controls
7.2.1.1. Independent Controls
7.2.1.2. Instrument Specific Controls
7.2.2. OEM Controls
Chapter 8. In Vitro Diagnostics Quality Control Market: End-use Estimates & Trend Analysis
8.1. In Vitro Diagnostics Quality Control Market: End-use Movement Analysis
8.2. In Vitro Diagnostics Quality Control Market Estimates and & Forecast, by End-use (USD Million)
8.2.1. Hospitals
8.2.2. Laboratories
8.2.3. Home Care
8.2.4. Others
Chapter 9. In Vitro Diagnostics Quality Control Market: Regional Estimates & Trend Analysis, by Product, Type, Application, Manufacturer Type, and End-use
9.1. In Vitro Diagnostics Quality Control Market: Regional Outlook
9.2. North America
9.2.1. North America in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. U.S. In Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.2.3. Competitive/Market Scenario
9.2.2.4. Regulatory Framework
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Canada in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.3.3. Competitive/Market Scenario
9.2.3.4. Regulatory Framework
9.3. Europe
9.3.1. Europe in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Uk in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.2.3. Competitive/Market Scenario
9.3.2.4. Regulatory Framework
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Germany in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.3.3. Competitive/Market Scenario
9.3.3.4. Regulatory Framework
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. France in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.4.3. Competitive/Market Scenario
9.3.4.4. Regulatory Framework
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Italy in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.5.3. Competitive/Market Scenario
9.3.5.4. Regulatory Framework
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Spain in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.6.3. Competitive/Market Scenario
9.3.6.4. Regulatory Framework
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Denmark in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.7.3. Competitive/Market Scenario
9.3.7.4. Regulatory Framework
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Sweden in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.8.3. Competitive/Market Scenario
9.3.8.4. Regulatory Framework
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Norway in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.3.9.3. Competitive/Market Scenario
9.3.9.4. Regulatory Framework
9.4. Asia-Pacific
9.4.1. Asia-Pacific in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Japan in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.2.3. Competitive/Market Scenario
9.4.2.4. Regulatory Framework
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. China in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.3.3. Competitive/Market Scenario
9.4.3.4. Regulatory Framework
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. India in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.4.3. Competitive/Market Scenario
9.4.4.4. Regulatory Framework
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Australia in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.5.3. Competitive/Market Scenario
9.4.5.4. Regulatory Framework
9.4.6. Thailand
9.4.6.1. Key Country Dynamics
9.4.6.2. Thailand in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.6.3. Competitive/Market Scenario
9.4.6.4. Regulatory Framework
9.4.7. South Korea
9.4.7.1. Key Country Dynamics
9.4.7.2. South Korea in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.4.7.3. Competitive/Market Scenario
9.4.7.4. Regulatory Framework
9.5. Latin America
9.5.1. Latin America in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Brazil in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.2.3. Competitive/Market Scenario
9.5.2.4. Regulatory Framework
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Mexico in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.3.3. Competitive/Market Scenario
9.5.3.4. Regulatory Framework
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Argentina in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5.4.3. Competitive/Market Scenario
9.5.4.4. Regulatory Framework
9.6. MEA
9.6.1. MEa in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. South Africa in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.2.3. Competitive/Market Scenario
9.6.2.4. Regulatory Framework
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Saudi Arabia. In Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.3.3. Competitive/Market Scenario
9.6.3.4. Regulatory Framework
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. UAe in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.4.3. Competitive/Market Scenario
9.6.4.4. Regulatory Framework
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Kuwait in Vitro Diagnostics Quality Control Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6.5.3. Competitive/Market Scenario
9.6.5.4. Regulatory Framework
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Participant’s Overview
10.3. Financial Performance
10.4. Product Benchmarking
10.4.1. In Vitro Diagnostics Quality Control Market Share Analysis, 2023
10.4.2. Company Market Share, 2023 for Plasma-based Controls
10.4.3. Company Market Share, 2023 for Serum-based Controls
10.4.4. Company Market Share, 2023 for Whole Blood-based Controls
10.5. Strategy Mapping
10.5.1. Mergers & Acquisitions
10.5.2. Partnerships & Collaborations
10.5.3. Expansion
10.5.4. Product Approval & Launch
10.5.5. Others
Chapter 11. Company Profiles
11.1. Company Categorization
11.2. Participant’s Overview
11.2.1. Siemens Healthineers AG
11.2.2. Abbott
11.2.3. Bio-Rad Laboratories, Inc.
11.2.4. Danaher
11.2.5. F. Hoffmann-La Roche Ltd
11.2.6. Sysmex Corporation
11.2.7. QuidelOrtho Corporation
11.2.8. Randox Laboratories Ltd
11.2.9. Helena Laboratories Corporation
11.2.10. Thermo Fisher Scientific, Inc.
11.2.11. SeraCare Life Sciences, Inc.
11.2.12. BD
11.2.13. Merck KGaA
11.2.14. QIAGEN
11.2.15. Hologic, Inc.
11.2.16. Bio-Techne
11.2.17. Fortress Diagnostics
11.2.18. Microbiologics
11.2.19. TRINA BIOREACTIVES AG
11.2.20. ConeBioproducts
11.2.21. Biorex Diagnostics
11.3. Financial Performance
11.4. Product Benchmarking
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 in Vitro Diagnostics Quality Control Market Revenue Estimates and Forecast, by Product, 2018-2030 (USD Million)
Table 4 in Vitro Diagnostics Quality Control Market Revenue Estimates and Forecast, by Type, 2018-2030 (USD Million)
Table 5 in Vitro Diagnostics Quality Control Market Revenue Estimates and Forecast, by Application, 2018-2030 (USD Million)
Table 6 in Vitro Diagnostics Quality Control Market Revenue Estimates and Forecast, by Manufacturer Type, 2018-2030 (USD Million)
Table 7 in Vitro Diagnostics Quality Control Market Revenue Estimates and Forecast, by End-use, 2018-2030 (USD Million)
Table 8 the Classification of Levels of IVd in South Africa
Table 9 Company Market Share, 2023
List of Figures
Figure 1 in Vitro Diagnostics Quality Control Market Segmentation
Figure 2 Market Research Process
Figure 3 Data Triangulation Techniques
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value-chain-based Sizing & Forecasting
Figure 7 QFD Modeling for Market Share Assessment
Figure 8 Market Formulation & Validation
Figure 9 Market Snapshot
Figure 10 Product and Type Segment Snapshot
Figure 11 Application and Manufacturer Type Segment Snapshot
Figure 12 End-use Segment Snapshot
Figure 13 Competitive Landscape Snapshot
Figure 14 in Vitro Diagnostics Market Value, 2023 (USD Billion)
Figure 15 Market Dynamics
Figure 16 PESTEL Analysis
Figure 17 Porter’s Five Forces Analysis
Figure 18 in Vitro Diagnostics Quality Control Market: Product Outlook and Key Takeaways
Figure 19 in Vitro Diagnostics Quality Control Market: Product Movement Analysis
Figure 20 Controls Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 21 Controls Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 22 Total Protein Estimates and Forecast, 2018-2030 (USD Million)
Figure 23 Total Protein Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 24 Albumin Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 25 Albumin Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 26 Blood Urea Nitrogen Estimates and Forecast, 2018-2030 (USD Million)
Figure 27 Blood Urea Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 28 Uric Acid Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 29 Uric Acid Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 30 Creatinine Estimates and Forecast, 2018-2030 (USD Million)
Figure 31 Creatinine Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 32 Sodium Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 33 Sodium Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 34 Potassium Estimates and Forecast, 2018-2030 (USD Million)
Figure 35 Potassium Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 36 Chloride Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 37 Chloride Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 38 Calcium Estimates and Forecast, 2018-2030 (USD Million)
Figure 39 Calcium Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 40 Magnesium Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 41 Magnesium Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 42 Inorganic Phosphorus Estimates and Forecast, 2018-2030 (USD Million)
Figure 43 Inorganic Phosphorous Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 44 Aspartate Transaminase Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 45 Aspartate Transaminase Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 46 Creatine Kinase Estimates and Forecast, 2018-2030 (USD Million)
Figure 47 Creatine Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 48 Gamma Glutamyl Transferase Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 49 Gamma Glutamyl Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 50 Total Bilirubin Estimates and Forecast, 2018-2030 (USD Million)
Figure 51 Total Bilirubin Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 52 Glucose Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 53 Glucose Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 54 C-reactive Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 55 C-reactive Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 56 Iron Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 57 Iron Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 58 Alanine Transaminase Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 59 Alanine Transaminase Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 60 Alkaline Phosphatase Estimates and Forecast, 2018-2030 (USD Million)
Figure 61 Alkaline Phosphatase Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 62 Alpha Amylase Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 63 Alpha Amylase Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 64 Total Cholesterol Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 65 Total Cholesterol Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 66 Triglyceride Estimates and Forecast, 2018-2030 (USD Million)
Figure 67 Triglyceride Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 68 Lactate Dehydrogenase Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 69 Lactate Dehydrogenase Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 70 Immunoglobulin G Estimates and Forecast, 2018-2030 (USD Million)
Figure 71 Immunoglobulin G Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 72 Immunoglobulin a Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 73 Immunoglobulin a Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 74 Immunoglobulin M Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 75 Immunoglobulin M Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 76 Complement 3market Estimates and Forecast, 2018-2030 (USD Million)
Figure 77 Complement 3 Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 78 Complement 4 Estimates and Forecast, 2018-2030 (USD Million)
Figure 79 Complement 4 Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 80 Rheumatoid Factor Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 81 Rheumatoid Factor Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 82 Anti-streptolysin -O Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 83 Anti-streptolysin -O Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 84 Beta 2 Microglobulin Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 85 Beta 2 Microglobulin Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 86 Cystatin-C Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 87 Cystatin-C Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 88 Myoglobin Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 89 Myoglobin Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 90 Troponin t and I Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 91 Troponin t and I Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 92 Others Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 93 Others Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 94 Calibrators Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 95 Calibrators Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 96 Others Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 97 Others Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 98 in Vitro Diagnostics Quality Control Market: Type Movement Analysis
Figure 99 in Vitro Diagnostics Quality Control Market: Type Outlook and Key Takeaways
Figure 100 Quality Controls Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 101 Quality Controls Assurance Services Estimates and Forecast, 2018-2030 (USD Million)
Figure 102 Plasma-based Control Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 103 Plasma-based Control Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 104 Serum-based Control Estimates and Forecast, 2018-2030 (USD Million)
Figure 105 Serum-based Control Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 106 Whole Blood-based Control Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 107 Whole Blood-based Control Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 108 Others Estimates and Forecast, 2018-2030 (USD Million)
Figure 109 Others Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 110 Quality Assurance Services Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 111 Data Management Solutions Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 112 in Vitro Diagnostics Quality Control Market: Application Movement Analysis
Figure 113 in Vitro Diagnostics Quality Control Market: Application Outlook and Key Takeaways
Figure 114 Immunochemistry Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 115 Immunochemistry Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 116 Hematology Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 117 Hematology Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 118 Clinical Chemistry Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 119 Clinical Chemistry Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 120 Alkaline Phosphatase (ALP) Molecular Diagnostics Estimates and Forecast, 2018-2030 (USD Million)
Figure 121 Alkaline Phosphatase (ALP) Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 122 Alanine Transaminase (ALT) Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 123 Alanine Transaminase (ALT) Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 124 Aspartate Transaminase (AST) Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 125 Aspartate Transaminase (AST) Phosphatase Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 126 Creatine Kinase MB (CK-MB) Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 127 Creatine Kinase MB (CK-MB) Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 128 Albumin Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 129 Albumin Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 130 Creatinine Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 131 Creatinine Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 132 Glucose Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 133 Glucose Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 134 Triglycerides Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 135 Triglycerides Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 136 Amylase Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 137 Amylase Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 138 Others Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 139 Others Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 140 Molecular Diagnostics Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 141 Molecular Diagnostics Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 142 Coagulation Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 143 Coagulation Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 144 Microbiology Estimates and Forecast, 2018-2030 (USD Million)
Figure 145 Microbiology Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 146 Others Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 147 Others Market Estimates and Forecast, 2018-2030 (Number of Units, Thousands)
Figure 148 in Vitro Diagnostics Quality Control Market: Manufacturer Type Movement Analysis
Figure 149 in Vitro Diagnostics Quality Control Market: Manufacturer Type Outlook and Key Takeaways
Figure 150 Third-party Controls Market Estimates and Forecasts, 2018-2030
Figure 151 Independent Controls Market Estimates and Forecasts, 2018-2030
Figure 152 Instrument Specific Controls Market Estimates and Forecasts,2018-2030
Figure 153 OEM Controls Market Estimates and Forecasts,2018-2030
Figure 154 in Vitro Diagnostics Quality Control Market: End-use Movement Analysis
Figure 155 in Vitro Diagnostics Quality Control Market: End-use Outlook and Key Takeaways
Figure 156 Hospitals Market Estimates and Forecasts, 2018-2030
Figure 157 Laboratories Market Estimates and Forecasts,2018-2030
Figure 158 Home Care Market Estimates and Forecasts, 2018-2030
Figure 159 Others Market Estimates and Forecasts,2018-2030
Figure 160 in-vitro Diagnostics Quality Control Market Revenue, by Region, 2023 & 2030 (USD Million)
Figure 161 Regional Marketplace: Key Takeaways
Figure 162 Regional Marketplace: Key Takeaways
Figure 163 North America in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 164 Key Country Dynamics
Figure 165 U.S. In Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 166 Key Country Dynamics
Figure 167 Canada in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 168 Europe in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 169 Key Country Dynamics
Figure 170 Uk in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 171 Key Country Dynamics
Figure 172 Germany in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 173 Key Country Dynamics
Figure 174 France in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 175 Key Country Dynamics
Figure 176 Italy in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 177 Key Country Dynamics
Figure 178 Spain in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 179 Key Country Dynamics
Figure 180 Denmark in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 181 Key Country Dynamics
Figure 182 Sweden in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 183 Key Country Dynamics
Figure 184 Norway in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 185 Rest of Europe in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 186 Asia-Pacific in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 187 Key Country Dynamics
Figure 188 Japan in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 189 Key Country Dynamics
Figure 190 China in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 191 Key Country Dynamics
Figure 192 India in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 193 Key Country Dynamics
Figure 194 Australia Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 195 Key Country Dynamics
Figure 196 Thailand in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 197 Key Country Dynamics
Figure 198 South Korea in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 199 Rest of Asia-Pacific in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 200 Latin America in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 201 Key Country Dynamics
Figure 202 Brazil in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 203 Key Country Dynamics
Figure 204 Mexico in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 205 Key Country Dynamics
Figure 206 Argentina in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 207 Rest of Latin America in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 208 MEa in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 209 Key Country Dynamics
Figure 210 South Africa in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 211 Key Country Dynamics
Figure 212 Saudi Arabia in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 213 Key Country Dynamics
Figure 214 UAe in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 215 Key Country Dynamics
Figure 216 Kuwait in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 217 Rest of MEa in Vitro Diagnostics Quality Control Market Estimates & Forecast, 2018-2030 (USD Million)
Figure 218 Key Company Categorization
Figure 219 in Vitro Diagnostics Quality Control Market Share Analysis, 2023
Figure 220 Company Market Share, 2023 for Plasma-based Controls
Figure 221 Company Market Share, 2023 for Serum-based Controls
Figure 222 Company Market Share, 2023 for Whole Blood-based Controls
Figure 223 Strategy Mapping

Companies Mentioned

  • Siemens Healthineers AG
  • Abbott
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Sysmex Corporation
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd
  • Helena Laboratories Corporation
  • Thermo Fisher Scientific, Inc.
  • SeraCare Life Sciences, Inc.
  • BD
  • Merck KGaA
  • QIAGEN
  • Hologic, Inc.
  • Bio-Techne
  • Fortress Diagnostics
  • Microbiologics
  • TRINA BIOREACTIVES AG
  • ConeBioproducts
  • Biorex Diagnostics

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.59 Billion
Compound Annual Growth Rate3.2%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

In-Vitro Diagnostics Quality Control Market by Offering, Distributor, Application, End-User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Quality Control Market by Offering, Distributor, Application, End-User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 - Product Image

In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

  • Report
  • 178 Pages
  • Global
From
In Vitro Diagnostics Quality Control Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

In Vitro Diagnostics Quality Control Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 90 Pages
  • Global
From
In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides - Product Image

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

  • Report
  • 367 Pages
  • Global
From
In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By End-use (Hospitals, Laboratory), By Technology (Immunoassay, Coagulation), By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents), By Test Location, By End-use (Hospitals, Laboratory), By Technology (Immunoassay, Coagulation), By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.